Alliance Pharma PLC represents strong values and corporate philosophy in its operations. The company focuses on providing innovative healthcare solutions to improve patient outcomes and enhance the quality of life. Alliance Pharma prioritizes integrity, accountability, and transparency in all aspects of its business. With a customer-centric approach, the company aims to deliver high-quality products and services, while fostering strong relationships with healthcare professionals and patients. Alliance Pharma is committed to driving growth, expanding its product portfolio, and ensuring regulatory compliance. Through continuous research and development, the company strives to address unmet medical needs and contribute positively to the healthcare industry.

Alliance Pharma PLC is primarily present in the United Kingdom, Europe, and international markets.

Alliance Pharma PLC has achieved several significant milestones throughout its history. The company has demonstrated consistent growth and expansion, with a strong focus on strategic acquisitions and partnerships. Notably, Alliance Pharma successfully completed the acquisition of Sinclair Pharma's dermatology division in 2015, enhancing its product portfolio and market presence. It has also achieved key regulatory approvals for various products, enabling global distribution and sales. Additionally, Alliance Pharma has consistently delivered strong financial performance, with steady revenue growth and increased profitability over the years. These milestones signify the company's commitment to innovation, market leadership, and delivering value to its shareholders.

Alliance Pharma PLC is a reputable and established pharmaceutical company with a rich history. It was founded in 1998 and is headquartered in the United Kingdom. The company focuses on acquiring and licensing healthcare products and medicines to expand its extensive portfolio. Alliance Pharma PLC has successfully grown through collaborations with other pharmaceutical companies, allowing them to offer an extensive range of prescription and over-the-counter products to consumers. With a steadfast commitment to innovation and quality, Alliance Pharma PLC has become a trusted name in the healthcare industry, providing reliable and effective solutions for various medical needs.

The main competitors of Alliance Pharma PLC in the market include companies such as GlaxoSmithKline, AstraZeneca, Pfizer, and Johnson & Johnson. These pharmaceutical giants are notable players in the industry and offer similar products and services as Alliance Pharma PLC. Despite the competitive landscape, Alliance Pharma PLC strives to stand out with its unique offerings and solutions, consistently delivering high-quality pharmaceutical products that cater to the needs of customers.

Alliance Pharma PLC is primarily active in the pharmaceutical industry.

Alliance Pharma PLC operates as a specialty pharmaceutical company. It focuses on acquiring, marketing, and distributing pharmaceutical products, as well as providing support services to healthcare professionals and patients. The company's business model revolves around sourcing and acquiring the rights to pharmaceutical and healthcare products, implementing sales and marketing strategies, and maintaining strong customer relationships. Alliance Pharma PLC aims to deliver sustainable growth through its diversified product portfolio, enhancing operational efficiency, and expanding its global presence in niche therapeutic areas.

مُعامل القيمة السوقية إلى الأرباح لـ Alliance Pharma هو ٨٫١٩.

مُعامِل القيمة إلى المبيعات Alliance Pharma هو ١٫٠٤.

نقاط جودة AlleAktien لـ Alliance Pharma هي 6/10.

المتوقعة Alliance Pharma الإيرادات هي ١٩٥٫٠٣ مليون. GBP.

صافي الربح المتوقعة Alliance Pharma هو ٢٤٫٦٦ مليون. GBP.

Alliance Pharma PLC is a British company specializing in the development, manufacturing, and marketing of over-the-counter medicines and healthcare products. The company offers a wide range of products in various business sectors, including dermatological products, pain relievers, infection protection, orthopedic products, and ophthalmological products. Alliance Pharma distributes its products in several European countries and other international markets through online platforms, pharmacies, and drugstores. The company aims to expand its business model by acquiring other companies and developing new products in different categories. With a strong commitment to innovation and customer service, Alliance Pharma has a solid foundation and promising growth prospects for the future.

يوزع Alliance Pharma أرباحًا قدرها ٠٫٠٢ GBP من خلال عمليات توزيع موزعة على مدار السنة.

لا يمكن حساب الأرباح السنوية لـ Alliance Pharma في الوقت الحالي أو أن الشركة لا توزع أرباحًا.

الرمز الدولي للأوراق المالية الخاص بـAlliance Pharma هو GB0031030819.

رمز WKN لـ Alliance Pharma هو 913253.

الرمز المُختصر لـ Alliance Pharma هو APH.L.

خلال آخر 12 شهراً، دفعت Alliance Pharma توزيعات أرباح بقيمة ٠٫٠٢ GBP . وهذا يعادل عائد توزيعات أرباح يقارب ٦٫٣٣ %. ومن المتوقع أن تدفع Alliance Pharma خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ٠٫٠٢ GBP.

نسبة توزيعات الأرباح الحالية لـ Alliance Pharma هي ٦٫٣٣ %.

Alliance Pharma يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر يناير, يوليو, يناير, يوليو.

Alliance Pharma دفعت توزيعات الأرباح كل عام خلال الـ0 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة ٠٫٠٢ GBP. وهذا يعادل عائد توزيعات أرباح قدره ٦٫٣٩ %.

Alliance Pharma يُصنف ضمن قطاع 'الصحة'.

لكي تستلم آخر توزيعات أرباح بقيمة ٠٫٠١٢ GBP من Alliance Pharma المُعلن عنها في ١٨‏/٧‏/٢٠٢٣، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ٢٢‏/٦‏/٢٠٢٣.

تم توزيع آخر دفعة من الأرباح بتاريخ ١٨‏/٧‏/٢٠٢٣.

في العام 2023، وزعت Alliance Pharma ٠٫٠١٧ GBP كأرباح أسهم.

يتم توزيع أرباح Alliance Pharma بالعملة GBP.